What Is Renal Cell Carcinoma? It's the most common type of kidney cancer. Although it’s a serious disease, finding and treating it early makes it more likely that you’ll be cured. No matter ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

Renal cell carcinoma highlights from ASCO GU 2025 include follow-up data from the CheckMate 9ER study, updated COSMIC-313 results, and promising early data on casdatifan, a new HIF-2 alpha inhibitor.

Renal cell carcinoma (RCC) refers to a heterogenous group of cancers that originate in the proximal convoluted tubule of the kidney. The three most common forms of RCC are clear cell RCC ...

KIM-1 as a circulating biomarker in metastatic RCC: Post-hoc analysis of JAVELIN Renal 101. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not ...

mRCC, metastatic renal cell carcinoma; OS, overall survival; PFS, progression-free survival. Primary insurance status was categorized into three groups—patients with Medicare, private insurance, and ...

Fruzaqla given in combination with sintilimab slowed progression in the second line for those with locally advanced or metastatic renal cell carcinoma.

A study identified a link between sex hormones and renal cell carcinoma, suggesting potential new treatment strategies.

Considering taking supplements to treat renal cell carcinoma? Below is a list of common natural remedies used to treat or reduce the symptoms of renal cell carcinoma. Follow the links to read ...

Get Instant Summarized Text (Gist) The CLEAR study highlights the importance of tumor size reduction in enhancing survival outcomes for advanced renal cell carcinoma (aRCC) patients. The ...

The following is a summary of “Metabolic syndrome and increased susceptibility to renal cell carcinoma – a meta-analysis,” published in the February 2025 issue of BMC Nephrology by Zhou et al.